A5263

A Randomized Comparison of Three Regimens of Chemotherapy with Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource Limited Settings

Sponsors:
US National Institute of Allergy and Infectious Diseases (NIAID)
The National Cancer Institute (NCI)
National Institute of Dental Craniofacial Research (NIDCR)

Protocol Summary:
A5263 is a prospective, randomized, active-controlled clinical trial to compare oral etoposide (ET) plus ART or bleomycin/vincristine (BV) plus ART to paclitaxel (PTX) plus ART for the treatment of advanced AIDS-related Karposi’s sarcoma (KS) in resource limited settings.

Years: 2013 – present

Investigator: Margaret Borok-Williams, MD, CHB, MMED

Location: Parirenyatwa CRS

ACTG

Current Study

Comments are closed.

Website by Canton Becker